{"name":"Complix","permalink":"complix","crunchbase_url":"http://www.crunchbase.com/company/complix","homepage_url":"http://www.complix.com/","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"info@complix.com","phone_number":"+32 (0)9 241 57 15","description":"","created_at":"Fri Jun 11 01:02:11 UTC 2010","updated_at":"Thu Feb 03 04:48:44 UTC 2011","overview":"<p>Complix is a biopharmaceutical company focused on the discovery and development of Alphabodiesâ„¢, a novel class of biopharmaceuticals that offer significant advantages over existing protein based therapies. Alphabodiesâ„¢ bind with high affinity to a wide range of disease targets and are particularly suited to address certain targets that are difficult to reach with antibodies or other types of protein scaffolds. Due to their unique stability and versatility Alphabodiesâ„¢ can be delivered via alternative non-injectable routes of administration, unlike most therapeutic proteins.</p>","image":{"available_sizes":[[[150,59],"assets/images/resized/0009/0204/90204v1-max-150x150.png"],[[250,99],"assets/images/resized/0009/0204/90204v1-max-250x250.png"],[[302,120],"assets/images/resized/0009/0204/90204v1-max-450x450.png"]],"attribution":null},"products":[],"relationships":[],"competitions":[],"providerships":[],"total_money_raised":"$8.2M","funding_rounds":[{"round_code":"a","source_url":"http://onbiovc.com/complix-nv-series-a-62m/","source_description":"Complix, NV: Series A $6.2M","raised_amount":6200000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":10,"investments":[{"company":null,"financial_org":{"name":"Vesalius Biocapital Partners","permalink":"vesalius-biocapital-partners","image":{"available_sizes":[[[150,71],"assets/images/resized/0006/1558/61558v1-max-150x150.jpg"],[[185,88],"assets/images/resized/0006/1558/61558v1-max-250x250.jpg"],[[185,88],"assets/images/resized/0006/1558/61558v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"LRM","permalink":"limburgse-reconversie-maatschappij","image":{"available_sizes":[[[150,111],"assets/images/resized/0006/1570/61570v1-max-150x150.jpg"],[[181,135],"assets/images/resized/0006/1570/61570v1-max-250x250.jpg"],[[181,135],"assets/images/resized/0006/1570/61570v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"CRP Sante","permalink":"crp-sante","image":null},"person":null}]},{"round_code":"a","source_url":"http://www.finsmes.com/2011/02/complix-raises-additional-2m-from.html","source_description":"Complix Raises Additional â‚¬2M from CrÃ©dit Agricole Private Equity","raised_amount":2000000,"raised_currency_code":"EUR","funded_year":2011,"funded_month":2,"funded_day":2,"investments":[{"company":null,"financial_org":{"name":"CrÃ©dit Agricole Private Equity","permalink":"crdit-agricole-private-equity","image":{"available_sizes":[[[150,28],"assets/images/resized/0004/6060/46060v1-max-150x150.jpg"],[[250,47],"assets/images/resized/0004/6060/46060v1-max-250x250.jpg"],[[292,56],"assets/images/resized/0004/6060/46060v1-max-450x450.jpg"]],"attribution":null}},"person":null}]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"","address1":"BioVille","address2":"Agoralaan building A-bis","zip_code":"3590","city":"Diepenbeek","state_code":null,"country_code":"BEL","latitude":null,"longitude":null}],"milestones":[],"ipo":null,"video_embeds":[],"screenshots":[],"external_links":[]}